Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders
Shin Koike(Meiji Pharmaceutical University), Yuki Ogasawara(Meiji Pharmaceutical University), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Yasue Horiuchi(National Taiwan University), Akiko Kobori(Tokyo Metropolitan Institute of Medical Science), Tasuku Kayama(Tohoku University), Masanari Itokawa(Fujita Health University)
Cited by 15
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184
Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia
|Archives of General Psychiatry|2010|166